| Naeem M Amin, MD | |
|
1 Cooper Plz, Camden, NJ 08103-1461 | |
| (856) 342-2000 | |
| Not Available |
| Full Name | Naeem M Amin |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 37 Years |
| Location | 1 Cooper Plz, Camden, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659326833 | NPI | - | NPPES |
| 074021 | Medicaid | NJ | |
| 243435 | Other | AMERIGROUP/AMERICAID | |
| 7432737 | Other | AETNA/US HEALTHCARE | |
| 2K9848 | Other | HEALTHNET | |
| P00826075 | Other | RAILROAD MEDICARE-PALMETTO | |
| 0074021 | Medicaid | NJ | |
| 01077795500 | Other | AMERICHOICE | |
| 45177 | Other | NJ | UNIVERSITY HEALTH PLAN |
| 60016567 | Other | HORIZON | |
| 60016567 | Other | NJ | HORIZON NJ HEALTH |
| P3629766 | Other | OXFORD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 25MA07939800 (New Jersey) | Secondary |
| 208M00000X | Hospitalist | 25MA07939800 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Us Renal Care Vineland Dialysis | Vineland, NJ | Dialysis facility |
| Vineland Dialysis | Vineland, NJ | Dialysis facility |
| Inspira Medical Center Vineland | Vineland, NJ | Hospital |
| Inspira Medical Center Elmer | Elmer, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Excelcare Alliance Llc | 0941470082 | 14 |
News Archive
A study conducted by UK researchers has found no evidence to support the hypothesis that regular use of inhaled corticosteroids may have a beneficial effect on mortality outcomes among patients with coronavirus disease 2019 (COVID-19).
Results of the Phase III RE-LY(R) (Randomized Evaluation of Long-Term Anticoagulant Therapy, Warfarin, Compared to Dabigatran) study will be presented at the European Society of Cardiology (ESC) Congress in Barcelona on Sunday, Aug. 30. The primary objective of RE-LY was to assess the safety and efficacy of the investigational oral direct thrombin inhibitor, dabigatran etexilate, against the current standard therapy, warfarin, for the prevention of stroke in patients with atrial fibrillation (AF).
A new study by researchers at Monash University, Australia, has revealed that people who have been infected with COVID-19 showed sustained protection against reinfection for at least eight months.
The Elsevier Foundation is seeking new grant proposals for the 2010 Innovative Libraries in Developing Countries program. Sponsored by Elsevier, a leading global publisher of scientific, technical and medical information, the Innovative Libraries program provides grants to library programs in the developing world for innovative systems and services that improve access to scientific, technical and medical information.
Cyberonics, Inc. today announced results for the quarter ended October 29, 2010.
› Verified 3 days ago
| Entity Name | Cooper Physician Offices Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154369510 PECOS PAC ID: 2860396611 Enrollment ID: O20031122000067 |
News Archive
A study conducted by UK researchers has found no evidence to support the hypothesis that regular use of inhaled corticosteroids may have a beneficial effect on mortality outcomes among patients with coronavirus disease 2019 (COVID-19).
Results of the Phase III RE-LY(R) (Randomized Evaluation of Long-Term Anticoagulant Therapy, Warfarin, Compared to Dabigatran) study will be presented at the European Society of Cardiology (ESC) Congress in Barcelona on Sunday, Aug. 30. The primary objective of RE-LY was to assess the safety and efficacy of the investigational oral direct thrombin inhibitor, dabigatran etexilate, against the current standard therapy, warfarin, for the prevention of stroke in patients with atrial fibrillation (AF).
A new study by researchers at Monash University, Australia, has revealed that people who have been infected with COVID-19 showed sustained protection against reinfection for at least eight months.
The Elsevier Foundation is seeking new grant proposals for the 2010 Innovative Libraries in Developing Countries program. Sponsored by Elsevier, a leading global publisher of scientific, technical and medical information, the Innovative Libraries program provides grants to library programs in the developing world for innovative systems and services that improve access to scientific, technical and medical information.
Cyberonics, Inc. today announced results for the quarter ended October 29, 2010.
› Verified 3 days ago
| Entity Name | Excelcare Alliance Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891090510 PECOS PAC ID: 0941470082 Enrollment ID: O20110830000049 |
News Archive
A study conducted by UK researchers has found no evidence to support the hypothesis that regular use of inhaled corticosteroids may have a beneficial effect on mortality outcomes among patients with coronavirus disease 2019 (COVID-19).
Results of the Phase III RE-LY(R) (Randomized Evaluation of Long-Term Anticoagulant Therapy, Warfarin, Compared to Dabigatran) study will be presented at the European Society of Cardiology (ESC) Congress in Barcelona on Sunday, Aug. 30. The primary objective of RE-LY was to assess the safety and efficacy of the investigational oral direct thrombin inhibitor, dabigatran etexilate, against the current standard therapy, warfarin, for the prevention of stroke in patients with atrial fibrillation (AF).
A new study by researchers at Monash University, Australia, has revealed that people who have been infected with COVID-19 showed sustained protection against reinfection for at least eight months.
The Elsevier Foundation is seeking new grant proposals for the 2010 Innovative Libraries in Developing Countries program. Sponsored by Elsevier, a leading global publisher of scientific, technical and medical information, the Innovative Libraries program provides grants to library programs in the developing world for innovative systems and services that improve access to scientific, technical and medical information.
Cyberonics, Inc. today announced results for the quarter ended October 29, 2010.
› Verified 3 days ago
| Entity Name | Salem Physician Practices Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245705128 PECOS PAC ID: 3476892050 Enrollment ID: O20190226000892 |
News Archive
A study conducted by UK researchers has found no evidence to support the hypothesis that regular use of inhaled corticosteroids may have a beneficial effect on mortality outcomes among patients with coronavirus disease 2019 (COVID-19).
Results of the Phase III RE-LY(R) (Randomized Evaluation of Long-Term Anticoagulant Therapy, Warfarin, Compared to Dabigatran) study will be presented at the European Society of Cardiology (ESC) Congress in Barcelona on Sunday, Aug. 30. The primary objective of RE-LY was to assess the safety and efficacy of the investigational oral direct thrombin inhibitor, dabigatran etexilate, against the current standard therapy, warfarin, for the prevention of stroke in patients with atrial fibrillation (AF).
A new study by researchers at Monash University, Australia, has revealed that people who have been infected with COVID-19 showed sustained protection against reinfection for at least eight months.
The Elsevier Foundation is seeking new grant proposals for the 2010 Innovative Libraries in Developing Countries program. Sponsored by Elsevier, a leading global publisher of scientific, technical and medical information, the Innovative Libraries program provides grants to library programs in the developing world for innovative systems and services that improve access to scientific, technical and medical information.
Cyberonics, Inc. today announced results for the quarter ended October 29, 2010.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Naeem M Amin, MD 1 Federal St # 200, Camden, NJ 08103-1088 Ph: (856) 356-4924 | Naeem M Amin, MD 1 Cooper Plz, Camden, NJ 08103-1461 Ph: (856) 342-2000 |
News Archive
A study conducted by UK researchers has found no evidence to support the hypothesis that regular use of inhaled corticosteroids may have a beneficial effect on mortality outcomes among patients with coronavirus disease 2019 (COVID-19).
Results of the Phase III RE-LY(R) (Randomized Evaluation of Long-Term Anticoagulant Therapy, Warfarin, Compared to Dabigatran) study will be presented at the European Society of Cardiology (ESC) Congress in Barcelona on Sunday, Aug. 30. The primary objective of RE-LY was to assess the safety and efficacy of the investigational oral direct thrombin inhibitor, dabigatran etexilate, against the current standard therapy, warfarin, for the prevention of stroke in patients with atrial fibrillation (AF).
A new study by researchers at Monash University, Australia, has revealed that people who have been infected with COVID-19 showed sustained protection against reinfection for at least eight months.
The Elsevier Foundation is seeking new grant proposals for the 2010 Innovative Libraries in Developing Countries program. Sponsored by Elsevier, a leading global publisher of scientific, technical and medical information, the Innovative Libraries program provides grants to library programs in the developing world for innovative systems and services that improve access to scientific, technical and medical information.
Cyberonics, Inc. today announced results for the quarter ended October 29, 2010.
› Verified 3 days ago
Dr. Afaf A. Anter, D.O Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Dorrance 222, Camden, NJ 08103 Phone: 856-342-3150 Fax: 856-968-8418 | |
Dr. James Jingren Liu, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 856-342-2000 | |
Kalpana Thawani, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1600 Haddon Ave, Camden, NJ 08103 Phone: 856-757-3700 Fax: 856-668-8479 | |
Pratik S Shah, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 856-342-2000 | |
Dr. Gregory Hilditch, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 856-342-2000 | |
Okebugwu Kamalu, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 856-342-2000 | |
Maher Al-safadi, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 856-342-2000 Fax: 856-968-8418 |